Clinical Trial Update: Merkel Positron Emission Tomography (PET) Protocol [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a Merkel Cell Carcinoma PET protocol completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Merkel Cell Carcinoma

Snippet

Sponsor: Trans Tasman Radiation Oncology Group | Conditions: Merkel Cell Carcinoma | Phase 2 | Status: COMPLETED